Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | RARB | P10826 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4799586 | 1.00 | TSHR (0.50) | TSHRHTTMAPTMEN1THRB | |
| SCHEMBL29377792 | 0.93 | HTT (0.54) | TSHRHTTMAPTMEN1THRB | |
| SCHEMBL6283240 | 0.91 | HTT (0.57) | TSHRHTTMAPTMEN1THRB | |
| SCHEMBL28383720 | 0.91 | HTT (0.57) | TSHRHTTMAPTMEN1THRB | |
| SCHEMBL5460271 | 0.91 | HTT (0.57) | TSHRHTTMAPTMEN1THRB | |
| SCHEMBL31066788 | 0.91 | HTT (0.57) | TSHRHTTMAPTMEN1THRB | |
| SCHEMBL28659327 | 0.91 | HTT (0.57) | TSHRHTTMAPTMEN1THRB | |
| SCHEMBL4636780 | 0.91 | HTT (0.57) | TSHRHTTMAPTMEN1THRB | |
| SCHEMBL11084823 | 0.89 | HTT (0.48) | TSHRHTTMAPTMEN1THRB | |
| SCHEMBL31151404 | 0.86 | HSD17B10 (0.52) | TSHRHTTMAPTMEN1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 619 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12575565-B2 | Disinfectant/sanitizer solutions | STERILEX, LLC (US) | 2026-03-17 | — | — | US | claimed |
| US-20250332211-A1 | COMPOSITIONS FOR INHIBITING DEGRADATION OF HYALURONIC ACID AND METHODS OF USE THEREOF | EPIDARUS THERAPEUTICS LLC (US) | 2025-10-30 | — | — | US | claimed |
| US-12370231-B2 | Compositions for inhibiting degradation of hyaluronic acid and methods of use thereof | EPIDARUS THERAPEUTICS, LLC (US) | 2025-07-29 | — | — | US | claimed |
| CN-118931673-A | Treatment liquid, kit, method for producing treatment liquid, method for cleaning substrate, and method for treating substrate | 富士胶片株式会社 | 2024-11-12 | — | — | CN | claimed |
| CN-118931672-A | Treatment liquid, kit, method for producing treatment liquid, method for cleaning substrate, and method for treating substrate | 富士胶片株式会社 | 2024-11-12 | — | — | CN | claimed |
| CN-118318851-A | Water-based electric heating mite-killing liquid and preparation method thereof | 中山榄菊日化实业有限公司 | 2024-07-12 | — | — | CN | claimed |
| WO-2024110980-A1 | A TRANSPARENT SUBSTRATE HAVING AN ANTIMICROBIAL COATING AND AN ARTICLE THEREOF | SAINT-GOBAIN GLASS FRANCE (FR) | 2024-05-30 | — | — | WO | claimed |
| EP-4135699-A1 | PHARMACEUTICAL COMPOSITIONS | Shenzhen Pharmacin Co., Ltd. (CN) | 2023-02-22 | — | — | EP | claimed |
| CN-114364780-A | Treatment liquid, kit, method for producing treatment liquid, method for cleaning substrate, and method for treating substrate | 富士胶片株式会社 | 2022-04-15 | — | — | CN | claimed |
| WO-2021209025-A1 | PHARMACEUTICAL COMPOSITIONS | SHENZHEN PHARMACIN CO., LTD (CN) | 2021-10-21 | — | — | WO | claimed |
| US-5051212-A | A solvent an a chelate compound | THE PROCTER & GAMBLE COMPANY (US) | 1991-09-24 | — | — | US | claimed |
| EP-0399133-A1 | Detergent and cleaning compositions containing chelating agents | THE PROCTER & GAMBLE COMPANY (US) | 1990-11-28 | — | — | EP | claimed |
| EP-0317542-A2 | Hard-surface cleaning compositions containing iminodiacetic acid derivatives | THE PROCTER & GAMBLE COMPANY (US) | 1989-05-24 | — | — | EP | claimed |
| EP-0286167-A2 | Hard-surface cleaning compositions | THE PROCTER & GAMBLE COMPANY (US) | 1988-10-12 | — | — | EP | claimed |
| EP-0259340-A1 | PYRETHROID-CONTAINING PARASITICIDAL COMPOSITION | ROBERT YOUNG & COMPANY LIMITED (GB) | 1988-03-16 | — | — | EP | claimed |
| US-4634786-A | INTERMEDIATES FOR ZIEGLER CATALYSTS | LITHIUM CORPORATION OF AMERICA (US) | 1987-01-06 | — | — | US | claimed |
| WO-1986007525-A1 | PYRETHROID-CONTAINING PARASITICIDAL COMPOSITION | ROBERT YOUNG & COMPANY LIMITED (GB) | 1986-12-31 | — | — | WO | claimed |
| EP-0162908-A4 | PREPARATION OF ALKALINE EARTH METAL ORGANOMETALLIC COMPOUNDS. | LITHIUM CORP (US) | 1986-04-15 | — | — | EP | claimed |
| EP-0162908-A1 | PREPARATION OF ALKALINE EARTH METAL ORGANOMETALLIC COMPOUNDS | LITHIUM CORPORATION OF AMERICA (US) | 1985-12-04 | — | — | EP | claimed |
| WO-1985002176-A1 | PREPARATION OF ALKALINE EARTH METAL ORGANOMETALLIC COMPOUNDS | LITHIUM CORPORATION OF AMERICA (US) | 1985-05-23 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12575565-B2 | Disinfectant/sanitizer solutions | TAS2R1, TAS2R42, HAO2 | TSHR 919/4885HTT 908/4885MAPT 4558/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.